FDA inspection
Naari Pharma Private Limited: FDA inspection ending Jun 7, 2022
FDA inspection 1173862 · Official Action Indicated (OAI) · Rudrapur
Key facts
| Inspection ID | 1173862 |
|---|---|
| Firm | Naari Pharma Private Limited |
| FEI number | 3014247908 |
| Address | Plot No 14-16, 55-57, Sector 5 Iie, Pantnagar, Dist. Udham Singh Nagar |
| City | Rudrapur |
| Fiscal year | 2022 |
| Inspection end date | Jun 7, 2022 |
| Classification | Official Action Indicated (OAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data